538 related articles for article (PubMed ID: 33752671)
21. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
22. Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.
Huang NS; Si J; Yang BL; Quan CL; Chen JJ; Wu J
Cancer Med; 2018 Jan; 7(1):56-63. PubMed ID: 29271113
[TBL] [Abstract][Full Text] [Related]
23. Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience.
Addae JK; Sweeting RS; Meszoely IM; McCaffrey RL; Kauffmann RM; Kelley MC; Grau AM; Hewitt K
Breast Cancer Res Treat; 2024 Feb; 204(1):117-121. PubMed ID: 38087058
[TBL] [Abstract][Full Text] [Related]
24. Precise application of sentinel lymph node biopsy in patients with ductal carcinoma in situ: A systematic review and meta-analysis of real-world data.
Chiu CW; Chang LC; Su CM; Shih SL; Tam KW
Surg Oncol; 2022 Dec; 45():101880. PubMed ID: 36332555
[TBL] [Abstract][Full Text] [Related]
25. De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ.
Abdulla HA; Khalaf Y
Cureus; 2023 Apr; 15(4):e37383. PubMed ID: 37182081
[TBL] [Abstract][Full Text] [Related]
26. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy may be unnecessary for ductal carcinoma in situ of the breast that is small and diagnosed by preoperative biopsy.
Uemoto Y; Kondo N; Wanifuchi-Endo Y; Asano T; Hisada T; Nishikawa S; Katagiri Y; Terada M; Kato A; Okuda K; Sugiura H; Kato H; Takahashi S; Toyama T
Jpn J Clin Oncol; 2020 Dec; 50(12):1364-1369. PubMed ID: 32856072
[TBL] [Abstract][Full Text] [Related]
28. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ
Am J Surg; 2007 Aug; 194(2):172-5. PubMed ID: 17618799
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
30. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
32. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
[TBL] [Abstract][Full Text] [Related]
33. Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
Bellver G; Buch E; Ripoll F; Adrianzen M; Bermejo B; Burgues O; Julve A; Ortega J
J Surg Res; 2022 Mar; 271():145-153. PubMed ID: 34902737
[TBL] [Abstract][Full Text] [Related]
34. [A single-center retrospective study on axillary evaluation in 1 557 breast ductal carcinoma in situ patients between 2006 and 2016].
Si J; Quan CL; Mo M; Guo R; Su YH; Yang BL; Chen JJ; Shao ZM; Wu J
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):681-685. PubMed ID: 31474060
[No Abstract] [Full Text] [Related]
35. The use of sentinel lymph node biopsy in ductal carcinoma in situ.
Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W
Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Prendeville S; Ryan C; Feeley L; O'Connell F; Browne TJ; O'Sullivan MJ; Bennett MW
Breast; 2015 Jun; 24(3):197-200. PubMed ID: 25681861
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
38. Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables.
Phantana-Angkool A; Voci AE; Warren YE; Livasy CA; Beasley LM; Robinson MM; Hadzikadic-Gusic L; Sarantou T; Forster MR; Sarma D; White RL
Ann Surg Oncol; 2019 Nov; 26(12):3874-3882. PubMed ID: 31342378
[TBL] [Abstract][Full Text] [Related]
39. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ.
Collado MV; Ruiz-Tovar J; García-Villanueva A; Rojo R; Latorre L; Rioja ME; González-Palacios F
Clin Transl Oncol; 2010 Jul; 12(7):499-502. PubMed ID: 20615827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
